Check-Cap (NASDAQ:MBAI) Stock Price Down 7.5% – What’s Next?

Check-Cap Ltd (NASDAQ:MBAI)’s stock price traded down 7.5% during trading on Thursday . The stock traded as low as $1.46 and last traded at $1.47. 114,113 shares changed hands during trading, a decline of 1% from the average session volume of 115,824 shares. The stock had previously closed at $1.59.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings assumed coverage on Check-Cap in a report on Monday, January 26th. They set a “sell (d-)” rating on the stock. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Check-Cap Stock Down 7.5%

The company has a market cap of $10.72 million, a price-to-earnings ratio of -0.53 and a beta of 0.64. The firm’s fifty day moving average price is $1.71.

Check-Cap Company Profile

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review.